Molecure Spółka Akcyjna (MOC.WA)

Warsaw Stock Exchange · Financial statements, TTM figures and earnings dates

In fiscal year 2023 (ended December 31, 2023), Molecure Spółka Akcyjna reported revenue of PLN 3.7M and net income of −PLN 28.4M. Annual financial statements are available for fiscal years 2020 to 2023, taken from the company's ESEF annual reports (IFRS).

Open interactive financials →

Key financials

PLN	FY2023 2023-12-31	FY2022 2022-12-31	FY2021 2021-12-31	FY2020 2020-12-31
Income statement
Revenue	PLN 3.7M	PLN 7.5M	PLN 1.2M	PLN 124.9M
Operating income	−PLN 32.2M	−PLN 37.7M	−PLN 13.8M	PLN 73.7M
Net income	−PLN 28.4M	−PLN 36.0M	−PLN 13.6M	PLN 68.0M
Diluted EPS	−PLN 1.69	−PLN 2.56	−PLN 0.98	PLN 4.90
Cash flow
Operating cash flow	−PLN 23.3M	−PLN 34.1M	−PLN 13.5M	PLN 57.4M
Capital expenditure	PLN 362.2K	PLN 3.3M	PLN 2.5M	PLN 2.1M
Free cash flow	−PLN 23.7M	−PLN 37.4M	−PLN 15.9M	PLN 55.3M
Balance sheet
Cash and equivalents	PLN 64.0M	PLN 65.6M	PLN 102.0M	PLN 120.5M
Total assets	PLN 112.3M	PLN 91.8M	PLN 151.6M	PLN 157.2M
Total liabilities	PLN 11.3M	PLN 11.6M	PLN 10.4M	PLN 10.1M
Shareholders' equity	PLN 100.9M	PLN 80.2M	PLN 141.1M	PLN 147.1M

TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in PLN as reported; per-share data adjusted for stock splits.

Annual reports

More on the interactive page

The full MOC.WA page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.

Open MOC.WA financials →